Back to Directory

Argipressin

Performance & Endurance

Synthetic vasopressin for diabetes insipidus and vasodilatory shock.

Key Benefits

  • ✓Treats diabetes insipidus
  • ✓Vasopressor in shock
  • ✓Antidiuretic effects
  • ✓Used in cardiac arrest
  • ✓Hemostatic in GI bleeding

Dosing Information

Dosage Range
0.01-0.04 units/min IV
Frequency
Variable by indication
Typical Duration
Based on condition

Detailed Protocol

Administered via intravenous infusion for shock, or intramuscular/subcutaneous for diabetes insipidus. Dosing varies by indication. Medical use only.

About Argipressin

Argipressin is synthetic vasopressin (antidiuretic hormone, ADH), a nonapeptide with both antidiuretic (V2 receptor) and vasopressor (V1 receptor) effects. Used for diabetes insipidus, vasodilatory shock, and cardiac arrest. Also called arginine vasopressin.

Research Notes

Used clinically for decades. VASST trial examined use in septic shock. Standard treatment for central diabetes insipidus. Part of ACLS protocols.

Get Peptide Research Updates

Newsletter signup

Please wait...

Thanks for signing up! You will receive an email to confirm your subscription.

Potential Side Effects

  • •Ischemia risk
  • •Hyponatremia
  • •Abdominal cramping
  • •Angina
  • •Requires monitoring

Always consult with a healthcare professional before starting any peptide therapy.